SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project
PRESCRIBING THE RIGHT MEDICINE FOR CHILDREN
8.4 million in new research funding for national partnerships
June 16, 2017
Today, the University of Manitoba announced more than $8.4 million in new research funding provided by the Canadian Institutes of Health Research (CIHR), Research Manitoba, and the Children’s Hospital Foundation of Manitoba in partnership with other institutions across Canada.
Led by Dr. Terry Klassen in the Rady Faculty of Health Sciences at the University of Manitoba, the SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project will use real patients under carefully controlled situations to measure how well a medication works and how safe it is. Knowledge gained from trials will help doctors choose which medicines to prescribe.
Click here to download the full release.
Photo from left to right:
Dr. Jay Doering, Associate Vice-President (Partnerships), University of Manitoba
Mr. Terry Duguid, Member of Parliament for Winnipeg South, and Parliamentary Secretary to the Minister of Status of Women
Dr. Terry Klassen, CEO and Scientific Director Children’s Hospital Research Institute of Manitoba; Professor and Head, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba; Medical Director, Child Health Program, WRHA; and Academic Director, CHI
Dr. Brian Postl, Dean, Rady Faculty of Health Sciences & Vice-Provost (Health Sciences), University of Manitoba, and Chair, Research Manitoba
The Honourable Cliff Cullen, Minister of Growth, Enterprise and Trade, Province of Manitoba
Mr. Lawrence Prout, President and CEO, Children's Hospital Foundation of Manitoba Inc.
Research Manitoba - New Budget
April 13, 2017
A Message from Dr. Brian Postl, Chair of Research Manitoba Board of Directors:
Research Manitoba has a new annual budget of $15 million, which is a $2 million reduction from previous years. We will continue to promote and support, and coordinate the funding of, research in the health, natural and social sciences, engineering and the humanities in Manitoba.
The Board of Directors and staff are reviewing our budget and expected expenditures in the short term and will be undertaking a longer term strategic review of our activities. We are committed to keeping our stakeholders and members of the research community informed throughout this process.
Please send all inquiries or questions to firstname.lastname@example.org.
Follow @ResearchMB on twitter for news and updates.
MANITOBA AND GENOME CANADA INVEST IN RESEARCH IN CANADA’S ARCTIC - GENICE Project
$4 Million Investment for Genomics Research in Oil Spill Preparedness and Emergency Response in Arctic Marine Environment
Research Manitoba and The Government of Canada today announced $4 million in funding for GENICE: a large-scale applied research project (LSARP). LSARP is one of Genome Canada’s funding programs and is aimed at projects using genomic approaches to address challenges and opportunities of importance to Canada’s natural resources, including interactions between natural resources and the environment, thereby contributing to Canada’s bioeconomy and the well-being of Canadians.
(Photo from left to right)
Dr. Digvir Jayas, Vice-President (Research and International) and Distinguished Professor, University of Manitoba
Ms. Christina Weise, Chief Executive Officer, Research Manitoba
Dr. Simon Potter, Director of Operations, Genome Prairie
Dr. Gary Stern, Research Professor, Centre for Earth Observation Science (CEOS), University of Manitoba
Dr. Casey Hubert, Associate Professor, Department of Biological Sciences, University of Calgary
Ms. Sarah Guillemard, MLA for Fort Richmond
Terry Duguid, Parliamentary Secretary to the Minister of Families, Children and Social Development; Member of Parliament for Winnipeg South
$1.4M in Funding for MITACS
Research Manitoba and Mitacs announce funding to support innovation,
job creation, and skills development
December 2, 2015 - Today, Research Manitoba announced $1.4 million of funding to support research internships between researchers and local companies or not-for-profits.
Mitacs connects companies and not-for-profit organizations with local experts in the academic community to address their research and development challenges. These collaborations promote innovation in Manitoba.
Manitoba Dementia Research Chair
PROVINCE ANNOUNCES MORE MONEY FOR DEMENTIA RESEARCH IN MANITOBA
August 18, 2015 - More investments for research into dementia are being made through Research Manitoba and in partnership with the Alzheimer Society of Manitoba, Jobs and Economy Minister Kevin Chief announced today.
“With an aging population, there has never been a more important time to profile dementia research,” said Minister Chief. “We understand the contribution our seniors have made to this province and today’s announcement will put more resources in place so that we can better understand the best ways to treat and diagnose dementia.”
Today’s announcement recognizes Dr. Benedict Albensi as the recipient of the Manitoba Dementia Research Chair. Albensi is a professor in the department of pharmacology and therapeutics, faculty of health sciences, college of medicine, University of Manitoba and principal investigator, synaptic plasticity and cellular memory dysfunction in the neurodegenerative disorders division of St-Boniface Hospital Research Centre.
Team-Clusters Funding Announcement - First Recipients
Province invests $5.95 million in cutting-edge research to improve Manitobans' health outcomes.
An announcement on April 22, 2015 recognizes the Collaborative Research Team/Cluster Development Program’s first recipients:
- The Manitoba DEVelOpmenTal Origins of chronic diseases In children Network (DEVOTION) - led by Dr. Jonathan McGavock, Department of Pediatrics and Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba
- The Manitoba Personalized Lifestyle Research (TMPLR) Program - led by Dr. Peter Jones, Department of Food Science, Faculty of Agriculture and Food Sciences, University of Manitoba
- An Innovative Cancer Research Model: Integrated Multidisciplinary CCL Research Cluster - led by Dr. Spencer Gibson, Departments of Biochemistry and Medical Genetics and Immunology, College of Medicine, Faculty of Health Sciences, University of Manitoba and Director of CancerCare Manitoba’s joint cancer research centre with the University of Manitoba
2014 Applied Health Services Research Recipients
January 6, 2015 - Research Manitoba is pleased to announce the 2014 Applied Health Services Research Grants. The funds that support Research Manitoba’s Applied Health Services Grants are provided through the Winnipeg Regional Health Authority.
Research Manitoba partnered with Manitoba Health, the regional health authorities, and the George and Fay Yee Centre for Healthcare Innovation (CHI) to support applied health services research. This focus area is important to the health system in Manitoba and supports collaborations between policy makers, service providers, and researchers interested in working together to address health system challenges.
Province Establishes Research Manitoba
The Manitoba government is establishing Research Manitoba, a new research funding organization that will bring existing research funding sources into a single, co-ordinated organization, under the chairmanship of Dr. Brian Postl, Jobs and the Economy Minister Theresa Oswald announced today.
National MS Clinical Trial Receives Approval, Patients Recruitment to Start by November 1
Halifax, September 28, 2012
The Honourable Leona Aglukkaq, Minister of Health, today announced that a national MS clinical trial has received the necessary medical and ethical approvals required to proceed. The clinical trial is a collaborative initiative between the Government of Canada, the provinces and territories and the MS Society of Canada.
MHRC PROVIDES UPDATE ON MS CLINICAL TRIALS
September 27, 2012
The Manitoba Health Research Council (MHRC) today provided an update on the national call for proposals for clinical trials for studying the treatments for CCSVI in Multiple Sclerosis (MS).